| KPI | [EUR m] | Q2 2025 | FY 2025 | Q2 2026 E | FY 2026 E | FY 2027 E | FY 2028 E | FY 2029 E | FY 2030 E | FY 2031 E |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales revenue, Lab Products & Services | Number of Estimates | 18 | 18 | 18 | 18 | 15 | 15 | 7 | ||
| Sales revenue, Lab Products & Services | Highest | 174.9 | 695.3 | 750.8 | 805.3 | 863.9 | 926.7 | 913.6 | ||
| Sales revenue, Lab Products & Services | Consensus (Mean) | 167.4 | 673.0 | 171.1 | 687.2 | 723.1 | 763.8 | 806.2 | 850.3 | 888.7 |
| Sales revenue, Lab Products & Services | Median | 171.4 | 686.7 | 722.6 | 765.9 | 808.5 | 853.3 | 897.6 | ||
| Sales revenue, Lab Products & Services | Lowest | 167.6 | 677.4 | 701.1 | 732.6 | 765.6 | 796.9 | 823.8 | ||
| Sales revenue growth in constant currencies in %, Lab Products & Services | Number of Estimates | 17 | 18 | 18 | 18 | 15 | 15 | 7 | ||
| Sales revenue growth in constant currencies in %, Lab Products & Services | Highest | 6.7 | 5.6 | 7.3 | 7.3 | 7.3 | 7.3 | 6.0 | ||
| Sales revenue growth in constant currencies in %, Lab Products & Services | Consensus (Mean) | -2.6 | 0.2 | 4.3 | 4.0 | 5.2 | 5.6 | 5.6 | 5.4 | 5.1 |
| Sales revenue growth in constant currencies in %, Lab Products & Services | Median | 4.0 | 3.9 | 5.1 | 5.8 | 5.6 | 5.6 | 5.6 | ||
| Sales revenue growth in constant currencies in %, Lab Products & Services | Lowest | 2.6 | 2.7 | 3.5 | 4.0 | 4.0 | 3.1 | 2.1 | ||
| Underlying EBITDA, Lab Products & Services | Number of Estimates | 17 | 17 | 17 | 17 | 14 | 14 | 6 | ||
| Underlying EBITDA, Lab Products & Services | Highest | 37.0 | 161.7 | 178.8 | 189.5 | 188.8 | 205.3 | 200.5 | ||
| Underlying EBITDA, Lab Products & Services | Consensus (Mean) | 36.8 | 144.6 | 35.4 | 144.8 | 154.9 | 165.8 | 173.8 | 185.3 | 194.0 |
| Underlying EBITDA, Lab Products & Services | Median | 35.2 | 143.1 | 152.7 | 163.5 | 174.0 | 186.1 | 195.5 | ||
| Underlying EBITDA, Lab Products & Services | Lowest | 34.2 | 140.9 | 146.5 | 154.6 | 163.1 | 172.0 | 179.6 | ||
| Underlying EBITDA margin in %, Lab Products & Services | Number of Estimates | 17 | 17 | 17 | 17 | 14 | 14 | 6 | ||
| Underlying EBITDA margin in %, Lab Products & Services | Highest | 21.6 | 23.5 | 24.5 | 24.5 | 22.1 | 22.4 | 22.2 | ||
| Underlying EBITDA margin in %, Lab Products & Services | Consensus (Mean) | 22.0 | 21.5 | 20.7 | 21.1 | 21.4 | 21.7 | 21.6 | 21.8 | 21.9 |
| Underlying EBITDA margin in %, Lab Products & Services | Median | 20.7 | 20.8 | 21.0 | 21.3 | 21.5 | 21.8 | 22.0 | ||
| Underlying EBITDA margin in %, Lab Products & Services | Lowest | 19.9 | 20.5 | 20.8 | 21.0 | 21.2 | 21.4 | 21.6 |
This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.
